Cerebrovascular Events After TAVR May Be Especially Serious

Stroke events do not seem to be related to valve thrombosis or structural degeneration, but to a higher baseline risk in patients who undergo transcatheter aortic valve replacement (TAVR).

Efectos de la radiación cerebral en Cardiólogos Intervencionistas

About 1 in 20 patients who underwent TAVR experienced a stroke or transient ischemic attack during follow-up. According to this new analysis, the consequences of these events can be particularly catastrophic for the aforementioned population.

Most late strokes that occurred were disabling, and nearly one-third of patients who had them died during hospitalization.

While we wonder what can be done to mitigate the impact of these events, we can identify some certainties. There was echocardiographic data available for 58% of patients at the time of the cerebrovascular event, and the analysis did not suggest a relation between these events and valve thrombosis or structural valve degeneration.


Read also: Heart and Brain: Risk Factors, Atrial Fibrillation and Dementia.


In this sense, this work sheds some light on valve thrombosis. The vast majority of strokes occurred either at 1 year or later; consequently, thrombosis is not likely to be involved in the mechanism, since it is an event that seems to peak in the initial days and weeks following the procedure.

Of 3750 consecutive patients who underwent TAVR and survived beyond 30 days, 192 patients (5.1%) had a late cerebrovascular event, as was defined using the VARC-2 criteria, at a mean 16 months after the initial procedure. About 80% of all stroke events were ischemic, and all others were hemorrhagic.

Such stroke events were disabling for 70% of this population; the affected patients remaining died during hospitalization. These catastrophic results seem to be worse than the outcomes in a general population of similarly-aged patients, and comorbidities are apparently the key.


Read also: MR CLEAN Registry: “Time is Brain” is a Far More Accurate than “Time is Heart”.


The best predictor of late stroke after TAVR was prior stroke.

Original Title: Late cerebrovascular events following transcatheter aortic valve replacement.

Reference: Muntané-Carol G et al. J Am Coll Cardiol Intv. 2020; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....